Letters to the Editor

Evaluating the safety profile of defibrotide in sickle cell disease: an in vitro study

INNOVHEM, Creteil
INNOVHEM, Creteil
Universite Paris-Est Creteil, INSERM U955, IMRB, Laboratory of excellence LABEX, Creteil, France; Etablissement francais du sang, Creteil
Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital-UPEC, AP-HP, Creteil
Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital-UPEC, AP-HP, Creteil
INNOVHEM, Creteil
Universite Paris-Est Creteil, INSERM U955, IMRB, Laboratory of excellence LABEX, Creteil, France; Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital-UPEC, AP-HP, Creteil
Haematologica Early view May 8, 2025 https://doi.org/10.3324/haematol.2025.287447